Anti-pot proponents falsely claim that liberalized marijuana policies are associated with rising opioid abuse, but the scientific data says just the opposite.
According to a study published last year in the Journal of the American Medical Association Internal Medicine, the enactment of statewide medicinal marijuana laws is associated with significantly lower state-level opioid overdose mortality rates. Investigators conducted a time-series analysis of medical cannabis laws and state-level death certificate data in the United States from 1999 to 2010—a period during which 13 states instituted laws allowing for cannabis therapy.
“States with medical cannabis laws had a 24.8 percent lower mean annual opioid overdose mortality rate compared with states without medical cannabis laws,” researchers reported.
Specifically, they found that overdose deaths from opioids decreased by an average of 20 percent one year after the law’s implementation, 25 percent after two years and up to 33 percent by years five and six.
“[O]ur results suggest a link between medical cannabis laws and lower opioid analgesic overdose mortality,” investigators concluded.
A separate study published this month by the National Bureau of Economic Research, a non-partisan think-tank, shows that the JAMA data is not anomalous. Researchers from the RAND Corporation and the University of California, Irvine assessed the impact of medical marijuana laws on problematic opioid use, as measured by treatment admissions for opioid pain reliever addiction and by state-level opioid overdose deaths.
“[S]tates permitting medical marijuana dispensaries experience a relative decrease in both opioid addictions and opioid overdose deaths compared to states that do not,” they reported.
Researchers found that women over the age of 40 showed the most significant decrease in problematic opioid use.
The notion that chronic pain patients will choose pot over opiate pain relievers is hardly surprising. According to a series of clinical trials overseen by the University of California, San Diego, the inhalation of whole-plant cannabis is safe and efficacious in the treatment of various types of neuropathy—a type of pain that is poorly managed by opiates. Moreover, clinical data published in 2011 in the journal Clinical Pharmacology & Therapeutics showed that cannabis administration significantly augments the analgesic effects of opiates in patients with chronic pain.
The idea that cannabis can act as an adjunct—or, in some cases—as a substitute to opiates is welcome news.
Overdose deaths involving opioid analgesics have increased dramatically over the past decade. While fewer than 4,100 opiate-induced fatalities were reported for the year 1999, by 2010 this figure rose to over 16,600 according to an analysis by the U.S. Centers for Disease Control.
Dispensaries in British Columbia Told to Shut Down Before Legalization
Canadian Schools Struggling With Cannabis Education Ahead of Legalization
An American’s Quest to Find Fourth Meal in Canada
How to Choose the Best Synthetic Urine to Pass a Urine Test
First Ever Trial to Study the Effects of Microdosing LSD Began This Month
What Do The Colors of Marijuana Mean?
Coca-Cola in Talks to Make the Next CBD-Infused Beverage
Canada Estimates $1 Billion in Legal Cannabis Sales in First Three Months
Business5 days ago
Walmart Joins List of Mega-Chains Considering New Marijuana Products
Legalization6 days ago
Want Cannabis to be Reclassified? Tell The Trump Administration
Sponsored7 days ago
Everything You Wanted to Know About CBD Tinctures
News6 days ago
Denver’s Psilocybin Initiative Moves Forward to Signature Gathering Phase
Medical Marijuana6 days ago
Riviera Creek Brings Science and Tech to Ohio’s New Medical Cannabis Market
News7 days ago
The United Kingdom Will Have Medical Cannabis Within a Month
Edibles6 days ago
Washington State Cannabis Board Bans Most Weed-Infused Candy
Culture6 days ago
Cannabis Sommeliers are Officially on the Brink of Existence